PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1
Authors
Keywords
-
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-11-22
DOI
10.1007/s00280-020-04188-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (HIF1A): An independent predictor of poor overall survival in chronic lymphocytic leukemia
- (2017) Christos K. Kontos et al. LEUKEMIA RESEARCH
- USP22 Induces Cisplatin Resistance in Lung Adenocarcinoma by Regulating γH2AX-Mediated DNA Damage Repair and Ku70/Bax-Mediated Apoptosis
- (2017) Aman Wang et al. Frontiers in Pharmacology
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer treatment and survivorship statistics, 2016
- (2016) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
- (2016) D.A. Fennell et al. CANCER TREATMENT REVIEWS
- CK2 inhibition induced PDK4-AMPK axis regulates metabolic adaptation and survival responses in glioma
- (2016) Deobrat Dixit et al. EXPERIMENTAL CELL RESEARCH
- Cyclin-Dependent Kinase 2 Promotes Tumor Proliferation and Induces Radio Resistance in Glioblastoma
- (2016) Jia Wang et al. Translational Oncology
- Non–Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases
- (2015) Hideko Isozaki et al. CANCER RESEARCH
- Krüppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling
- (2015) Adam R. Brown et al. CARCINOGENESIS
- ZBTB2 increases PDK4 expression by transcriptional repression of RelA/p65
- (2015) Min-Young Kim et al. NUCLEIC ACIDS RESEARCH
- Altered regulation of PDK4 expression promotes antiestrogen resistance in human breast cancer cells
- (2015) William Walter et al. SpringerPlus
- Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer
- (2015) Shuying Liu et al. Oncotarget
- The combinatory effects of PPAR-γ agonist and survivin inhibition on the cancer stem-like phenotype and cell proliferation in bladder cancer cells
- (2014) YANG WANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- PDK4 Protein Promotes Tumorigenesis through Activation of cAMP-response Element-binding Protein (CREB)-Ras Homolog Enriched in Brain (RHEB)-mTORC1 Signaling Cascade
- (2014) Zhibo Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells
- (2014) Pengliang Shen et al. PROSTATE
- The Evaluation of the FOXO1, KLF9 and YT521 Genes Expression in Human Endometrial Cancer
- (2013) Mohsen Korani et al. Clinical Laboratory
- Molecular mechanisms of cisplatin resistance in bladder cancer
- (2012) Ross M Drayton et al. Expert Review of Anticancer Therapy
- Role of Insulin-Like Growth Factor-1 Signaling Pathway in Cisplatin-Resistant Lung Cancer Cells
- (2011) Yunguang Sun et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- EPAS1 mRNA in plasma from colorectal cancer patients is associated with poor outcome in advanced stages
- (2011) N. MOHAMMED et al. Oncology Letters
- HIF1A Overexpression Is Associated with Poor Prognosis in a Cohort of 731 Colorectal Cancers
- (2010) Yoshifumi Baba et al. AMERICAN JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More